The FDA's new discussion paper proposes doctor-style competency testing for generative AI medical devices before they reach patients.
FDA marketing authorizations for AI-powered medical tools have passed 1,500, with oncology among the fastest-growing categories.
Happy Health raised $75M to build AI-powered home care around a smart ring that screens for sleep apnea.
GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and proteins shape whole-cell behavior.
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch lung biopsy robot.
Japanese bio-AI startup Craif banks $33M to push its urine-based pancreatic cancer test toward US launch.
An AI classifier trained on eye-movement data may spot amblyopia in patients who cannot complete standard vision tests.
Deep learning framework PRISM diagnoses liver lesions on contrast-free MRI, cutting radiologist reading time by up to two-thirds.